Case Study

A Streamlined Scientific Approach To Primary Packaging Solutions For Biologics


The selection of the appropriate primary packaging for an injectable drug product is one of the most crucial considerations in the drug development process – the wrong choice can cost significant time and resources. The increasing number of complex and sensitive biologics is only adding to the pressure to get it right first time.

A particular challenge when it comes to biologics is the issue of sensitivity. It has always been a problem for the pharmaceutical industry, but it is even more of an issue now that more drugs are biologics and highly concentrated. By some estimates, 20-30% of drug formulations now have sensitivity issues – reacting to one or more elements of their primary packaging and losing their stability.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.

Subscribe to Med Device Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Med Device Online